Bharat Biotech’s COVAXIN gets nod for phase 2/3 trials on 2-18 years old | Latest English News
As per the official sources, the trial for the vaccine will take place in 525 subjects at different sites, including AIIMS, Patna, AIIMS, Delhi, and Meditrina Institute of Medical Sciences, Nagpur.